KRAS and neoplasm: This inflammatory signature mirrors the tumor microenvironment of human KRAS-mutated gastric cancers, which often exhibit elevated interleukin-6 signaling and enhanced C-X-C motif chemokine ligand 1-mediated neutrophil recruitment.